Nexium (esomeprazole)

DRUG3 trials

Sponsors

Forest Laboratories, GlaxoSmithKline, Eisai Inc.

Conditions

DyspepsiaGastroesophageal Reflux DiseaseHealthyReflux, Gastroesophageal

Phase 1

A Study to Evaluate the Effect on 24-hour, Intragastric pH of RAB ER 50-mg Capsules Compared With Esomeprazole (Nexium) 40 mg Capsules and Rabeprazole (Aciphex) 20-mg Tablets

CompletedNCT01153659

Eisai Inc.Healthy

Start: 2010-07-31End: 2010-10-31Updated: 2013-11-01

Phase 2

The Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of Functional Dyspepsia.

CompletedNCT00303264

Forest LaboratoriesDyspepsia

Start: 2006-05-31End: 2007-08-31Updated: 2012-03-05

A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine.

CompletedNCT00405119

GlaxoSmithKlineGastroesophageal Reflux Disease, Reflux, Gastroesophageal

Start: 2006-05-31End: 2007-03-31Updated: 2017-01-19